Injective Refresher Review by Jesse

Welcome to this week's coin review where we take the time to research some of the latest projects available so you don’t have to. With a pretty dull market the last few weeks, a few new projects are launching amidst the new years' uncertainties. Aside from a few one off 50% bumps for a couple of select projects, everything else is either continuing its downtrend or holding that sideways momentum. With all that going on, we’re going to change things up just a bit this week and introduce a new “Flashback” variation of our usual weekly review. With so many great projects covered so early in their lifecycle, it only makes sense that we’d revisit some select projects that have come a long way since we first discussed their protocol. To kick off our first interaction we’ll be taking a look back at Injective Protocol to update everyone on exciting new developments and those on the horizon. It has been a long time since we interviewed them back in October 2020!

Refresher

Injective Protocol is a fully decentralized layer-2 DEX built for the next generation of decentralized derivatives exchange. The Injective Chain is a Tendermint-based IBC-compatible blockchain that supports a decentralized orderbook-based DEX protocol and a trustless ERC-20 token bridge to the Ethereum blockchain. It is the first fully decentralized layer-2 exchange protocol for decentralized perpetual swaps, futures, and spot trading that unlocks the full potential of decentralized derivatives and borderless DeFi. Every component of the protocol has been built to be fully trustless, censorship-resistant, publicly verifiable, and front-running resistant. By providing the unrestricted and unprecedented ability to express diverse views in the decentralized financial markets, Injective is striving to empower individuals with the ability to more efficiently allocate capital.

Become a Premium Wealth Mastery Subscriber to read the whole article + get weekly investment strategies on crypto, altcoins, NFTs and more

Already have an account? Click here to login.

Related Articles

Responses

You must be logged in to post a comment.